Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
47,000
Employees47,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
47,000
Employees47,000

LLY Key Statistics

Market cap
731.57B
Market cap731.57B
Price-Earnings ratio
63.93
Price-Earnings ratio63.93
Dividend yield
0.73%
Dividend yield0.73%
Average volume
3.19M
Average volume3.19M
High today
$775.72
High today$775.72
Low today
$761.00
Low today$761.00
Open price
$763.90
Open price$763.90
Volume
3.36M
Volume3.36M
52 Week high
$972.53
52 Week high$972.53
52 Week low
$677.09
52 Week low$677.09

LLY News

TipRanks 2d
Eli Lilly’s Orforglipron Study: A New Hope for Sleep Apnea and Obesity

Eli Lilly And Company ((LLY)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50%...

Sherwood News 2d
Pfizer, Lilly spend big on telehealth contracts: Lawmaker report

Pfizer and other pharmaceutical companies paid up to $2.45 million for a contract with an unnamed telehealth company, according to a report released by a group...

Pfizer, Lilly spend big on telehealth contracts: Lawmaker report
TipRanks 2d
Eli Lilly & Co: Promising Growth Prospects and Strategic Positioning Amid Competitive Pressures

Eli Lilly & Co, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Evan Seigerman from BMO Capital maintained a Buy rating...

Analyst ratings

83%

of 30 ratings
Buy
83.3%
Hold
10%
Sell
6.7%

More LLY News

TipRanks 3d
Eli Lilly and Incyte’s Rheumatoid Arthritis Study: Key Insights for Investors

Eli Lilly And Company ((LLY)), Incyte Corporation (($CC:INCY.CUR)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take...

TipRanks 4d
Eli Lilly’s Stock Is a ‘Coiled Spring,’ Says Jim Cramer

CNBC host Jim Cramer continues to pound the table on Eli Lilly’s (LLY) stock. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off!...

TipRanks 4d
Eli Lilly’s Weight-Loss Drug Faces New Competition from China

Eli Lilly’s (LLY) main competitor in the weight-loss drug category has always been European pharmaceutical giant Novo Nordisk (NVO), the maker of Wegovy. But no...

Seeking Alpha 5d
Eli Lilly's Omvoh wins Health Canada approval for Crohn’s disease

Eli Lilly (NYSE:LLY) has won Health Canada approval for Omvoh (mirikizumab) in patients with Crohn’s disease, the company said on Tuesday. Omvoh is now indicat...

Eli Lilly's Omvoh wins Health Canada approval for Crohn’s disease
TipRanks 6d
Eli Lilly’s Weight Management Study: A Potential Game-Changer?

Eli Lilly And Company ((LLY)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50%...

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.